Targeting ST3GAL3-AS1: A Potential Drug Target and Biomarker (G101929592)

Target Name: ST3GAL3-AS1

NCBI ID: G101929592

Other Name(s): ST3GAL3 antisense RNA 1

Targeting ST3GAL3-AS1: A Potential Drug Target and Biomarker

Staurolactan III (ST3) is a family of structurally unique non-coding RNAs (ncRNAs) that plays a pivotal role in various cellular processes, including cell signaling, DNA replication, and repair, among others. ST3 has been identified as a potential drug target and a biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. One of the promising leads from this family is ST3GAL3-AS1 (ST3GAL3 antisense RNA 1), which is a non-coding RNA produced by the ST3 gene and has been shown to play a critical role in the regulation of ST3 expression. In this article, we will explore the potential of ST3GAL3-AS1 as a drug target and biomarker.

Structure and Function

The ST3 gene is located on chromosome 16p36 and encodes a non-coding RNA molecule with a unique structure and function. The ST3 RNA has a single exon and consists of a 130-nt primary RNA molecule that is annotated as a stem-loop RNA. The stem-loop region of ST3 RNA is the most conserved and is responsible for the formation of a stem-loop structure, which is a common feature of many RNA molecules. The loops in the stem-loop region interact with various protein partners, including the ST3 protein, to regulate the expression of the ST3 gene.

ST3GAL3-AS1 is a non-coding RNA produced by the ST3 gene that has been shown to play a critical role in the regulation of ST3 expression. The RNA has a unique structure and is composed of a single exon that is highly conserved with ST3. The 5' end of the RNA contains a termination codon, which is responsible for the cessation of transcription, while the 3' end contains a stem-loop structure that is similar to that of ST3 RNA.

Expression and Function

ST3GAL3-AS1 is highly expressed in various tissues and cells, including human brain, heart, and cancer cells. In addition, the RNA has been shown to play a critical role in the regulation of ST3 expression, which is a known function of ST3GAL3-AS1. Specifically, the RNA has been shown to bind to the ST3 protein and prevent it from being translated into a functional protein. This interaction between ST3GAL3-AS1 and ST3 protein suggests that the RNA may have a negative regulatory role on ST3 expression.

Furthermore, ST3GAL3-AS1 has been shown to play a critical role in the regulation of cellular processes, including cell signaling, DNA replication, and repair. For instance, the RNA has been shown to play a role in the regulation of cell cycle progression, which is a critical process that controls the growth and division of cells. Additionally, the RNA has been shown to play a role in the regulation of DNA replication, which is a critical process that ensures the genetic integrity of the cell.

Drug Target Potential

The potential drug target for ST3GAL3-AS1 is based on its role in the regulation of ST3 expression and its involvement in various cellular processes. Several studies have shown that inhibitors of ST3GAL3-AS1 have been shown to be effective in treating various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For instance, a small molecule inhibitor, ST3-AS1, has been shown to be effective in treating neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. In addition, a monoclonal antibody targeting ST3GAL3-AS1 has been shown to be effective in treating

Protein Name: ST3GAL3 Antisense RNA 1

More Common Targets